Accordingly, we propose that this gene be designated wecH.
INTRODUCTION
The phosphoglyceride-linked form of enterobacterial common antigen (ECA PG ) is a glycolipid located on the cell-surface of all gram-negative enteric bacteria (23, 29, 31, 44, 45) . The carbohydrate portion of ECA PG GlcNAc-(1→ (28, 30) . In addition, the 6-position of the GlcNAc residues in the trisaccharide repeat units are nonstoichiometrically substituted with O-acetyl groups (14, 28) . The polysaccharide chains are covalently linked to diacylglycerophosphate via glycosidic linkage of the potential terminal reducing GlcNAc residue to the phosphate moiety of the phosphoglyceride (23, 24, 42) . The phosphoglyceride aglycone is integral component of the outer leaflet of the outer membrane, and thus it serves to anchor the polysaccharide chains to the surface of the cell.
A water-soluble cyclic form of ECA (ECA CYC ) has also been demonstrated to be present in many gram-negative enteric bacteria (7, 14, 28, 48) , and the available data suggest that ECA CYC may indeed occur in all members of the Enterobacteriaceae (19).
trisaccharide repeat units, and each molecule of ECA CYC contains from 0 to 4 O-acetyl
groups (15, 19) . Similar to ECA PG , the O-acetyl groups of ECA CYC are also linked to the 6-position of GlcNAc residues (14) .
It has recently been reported that the ECA PG of Salmonella enterica serovar Typhimurium functions as a virulence factor for oral infection in mice by rendering the organism more resistant to bile salts (40) . Similarly, ECA PG appears to be required for the resistance of E. coli K-12 to bile salts and short-chain fatty acids (unpublished resultes). However, the role of ECA PG in the resistance of these organisms to these compounds remains to be established. Furthermore, it is not known if ECA PG has a similar function in other gram-negative enteric bacteria. In contrast, there are no reports concerning the function of ECA CYC . In this regard, the periplasmic location and cyclic structure of ECA CYC are similar to the osmoregulated periplasmic glucans (OPGs)
synthesized by many gram-negative Protobacteria (11) . However, unlike the OPGs, the synthesis of ECA CYC does not appear to be osmoregulated (unpublished results).
Many of the genes and enzymes involved in the synthesis and assembly of both ECA PG and ECA CYC have been identified, and this information has been described in detail in previous reports (4, 5, 15, 19, 43, 44) . Briefly, most of the genes known to be involved in the assembly of ECA polysaccharide chains are located in the wec gene cluster which includes 12 genes located at 85.4 min on the E. coli chromosome (3, 10, 30, 39) . The trisaccharide repeat units of both forms of ECA are assembled by a common pathway on the cytoplasmic face of the cytoplasmic membrane as the undecaprenyllinked intermediate, Fuc4NAc-ManNAcA-GlcNAc-pyrophosphorylundecaprenol (lipid III) (15) . Lipid III is then translocated en bloc to the periplasmic face of the membrane
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MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this study are listed in Table 1 . Cells were grown at 37º C either in Luria-Burtani (LB) broth (36), on LB agar plates (36) , in proteose peptone beef extract broth (PPBE) (46) or in M9 minimal medium (36) containing 0.2% glucose (M9-glucose medium) as indicated. SOC medium was prepared as described by Miller (36) . Tetracycline, ampicillin, kanamycin and choramphenicol were added to media when appropriate to
give final concentrations of 10 µg/ml, 50 µg/ml, 30 µg/ml and 30 µg/ml, respectively.
Transductions were carried out using phage P1 vir as described by Silhavy et al. (47) .
Construction of plasmids. The 12.78-kb BamHI-EcoRI nucleotide fragment of plasmid pJun3 containing the entire wec gene cluster was assembled from individual smaller nucleotide fragments contained in three different plasmid constructs. The initial step in this assembly process was the restriction enzyme digestion of plasmid pRL105 (34) with enzymes BamHI-HindIII followed by the ligation of the 3.73-kb product into the corresponding sites of plasmid pBR322 to yield plasmid pJun1. The nucleotide fragments containing the remaining genes were subsequently incorporated by the successive ligation of two nucleotide fragments obtained by digestion of plasmids pCA32 and pCA53 (34) with the restriction enzymes HindIII-ClaI and ClaI-EcoRI, respectively.
Plasmid pRL172 containing the yiaH::KAN-2 insertion was obtained by polymerase chain reaction (PCR) amplification using Taq polymerase (Qiagen), the genomic DNA of strain PR4276 as the template and 5'-CGGAAGGTATAACCGCGCAT-3' and 5'-CCATCGGCCCAAAGTAAAGA-3' as forward and reverse primers, respectively. The The plates were then covered and incubated overnight at 37°C with gentle shaking. The plates were then subjected to centrifugation (3,000 rpm) for 10 min at 4°C using an Eppendorf 5810R centrifuge, and the supernatant solution in each well was discarded.
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The cell pellets were resuspended in 100 µl of osmotic shock buffer (0.5 M sucrose, 0.1 M Tris-HCl [pH 8.2] and 1 mM EDTA) and incubated for 10 min at 4°C. The plates were then once again subjected to centrifugation as described above, and the supernatant solutions were discarded. The cell pellets were resuspended in 100 µl of 5 mM MgSO 4 , incubated at 4°C for 10 min followed by centrifugation of the plates as described above.
An aliquot (25 µl) of the soluble periplasmic fraction from each well was then removed, transferred to the well of a fresh multi titre plate and assayed for the presence of ECA CYC using the passive hemagglutination inhibition assay.
Passive hemagglutination inhibition assays. Soluble periplasmic fractions (25 µl) contained in the wells of multi titre plates were mixed with 0.9% saline (15 µl), mono-specific polyclonal rabbit anti-ECA antiserum (10 µl) (43) and ECA PG -coated sheep erythrocytes (50 µl). The resulting suspensions were incubated for 1 h at 37°C, and the presence of ECA CYC was detected by its ability to inhibit hemagglutination as determined by visual inspection. ECA PG -coated erythrocytes were prepared using soluble whole cell extracts obtained from E. coli AB1133 as previously described (43) were carried out as previously described (19) . Fractions of 1 ml were collected, dried under a stream of nitrogen and the residues were taken up in 50 µl of deionized water. Fractions containing ECA PG were identified by an immunoblot procedure using mouse anti-ECA monoclonal antibody mAb898 (33, 35, 37) . The ECA PG containing fractions were pooled, dried under vacuum and then taken up in 100 ml of methanol and applied to the bed of a Sephadex LH-20 column (3 x 22 cm).
The column was developed with methanol, and fractions of 2 ml were collected. The fractions were dried under a stream of nitrogen, and the residues were taken up in 50 µl of deionized water. Those fractions containing ECA PG were identified by the aforementioned immunoblot procedure. The peak fractions containing ECA PG were pooled, and the ECA PG was further purified by preparative thin-layer chromatography on 20 x 20 cm glass plates coated with silica gel N-HR (0.2 mm). The sample was streaked as a continuous band at the origin, and plates were subsequently developed with 70%
ethanol. Sample was also applied in the same manner to a separate indicator plate that 
Mass spectrometry (MS) studies. Matrix-assisted laser desorption ionizationtime of flight (MALDI-TOF) mass spectra were obtained using an Applied Biosystems
Voyager-DE STR biospectrometry workstation. Samples were analyzed using a laser intensity of 2,550 in the reflector mode. The matrix was alpha-cyano-4-hydroxycinnamic acid (CHCA) at a concentration of 5 mg/ml in 50% acetonitrile/50% 0.1% trifluoroacetic acid in water. Sample preparation consisted of taking 2 µl of the sample and mixing it with 2 µl of the matrix followed by spotting 1.5 µl on a stainless steel MALDI plate.
Spectra were acquired in the negative mode.
NMR spectroscopy. All NMR experiments were recorded on Varian Inova 600
MHz NMR spectrometers at 25°C. A screen of 3,000 kanamycin-resistant mutants using the PHI assay resulted in the identification of one insertion mutant, strain PR4276, which appeared to contain markedly decreased amounts of ECA CYC in the soluble fraction released by osmotic shock (data not shown). Surprisingly, the total amounts of ECA CYC in the soluble fractions obtained from both the mutant and parental strains as determined by quantitative reverse-phase HPLC were the same (Table 2 ). However, quantification of the individual ECA CYC species in the soluble fractions obtained from both the parental and mutant strains revealed that the extracts obtained from the parental strain contained ECA CYC species that were substituted with from 0 to 4 O-acetyl groups per molecule (Fig. 1A) . In Amplification of the yiaH locus in the wild-type and mutant chromosomes using these primers yielded products of approximately 1,140-bp and 3,000-bp, respectively. Taken together, the above findings clearly support the conclusion that the transposome (2,001-bp) is inserted into the yiaH locus.
The yiaH::KAN-2 insertion was introduced into competent cells of strain KM32
by linear transformation using NotI digested DNA isolated from plasmid pRL172 (yiaH::KAN-2 on a 3.4-kb fragment cloned into pGEM-T-easy). One of the resulting transformants, strain PR4254, was used as the donor for phage P1-mediated transduction of the insertion mutation into wild-type strain W3110 to yield mutant strain PR4246.
Characterization of strain PR4246 confirmed that it possessed the yiaH::KAN-2 mutation. Thus, amplification of the yiaH gene of strain PR4246 by PCR using primer set yiaH-1/yiaH-2 yielded a product of 3,000-bp. Analysis of the ECA CYC isolated from strain PR4246 by reverse-phase HPLC also revealed a single peak that eluted at the same time as previously observed for ECA CYC molecules lacking O-acetyl groups ( Fig. 2A) . In contrast, extracts of the parental wild-type strain, W3110, contain ECA CYC molecules that possess from 0 to 4 O-acetyl groups (19) . Finally, the defect in the O-acetylation of (Fig. 2B ).
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Taken together, the above data strongly support the conclusion that the yiaH locus is the structural gene for the O-acetyltransferase that catalyzes the synthesis of O-acetyl groups of the ECA trisaccharide repeat unit of ECA CYC . This conclusion was further supported by the results of BLASTP and RPSBLAST searches of the National Center of Biotechnology Information (NCBI) data base using the putative yiaH gene product as a query. These analyses revealed that the YiaH protein has significant homology (E value = 6e-06) with the conserved domain characteristic of the pfam01757:Acyl_transf_3
(acyltransferase) family of enzymes found in a variety of organisms (Fig. 3) . These analyses also revealed that this gene product is present in all gram-negative enteric bacteria for which complete genome sequences have been determined.
The yiaH gene encodes a putative inner membrane protein of 331 amino acid residues (13) . Bioinformatic analysis of the primary structure of YiaH using the hidden Markov model topology predictor TMHMM (22) provided by the support services of the Center for Biological Sequence Analysis, Technical University of Denmark DTU (http://www.cbs.dtu.dk/index.shtml) revealed that the protein contains ten predicted transmembrane helices (Fig. 3) . (15) (Fig. 4) . As shown in the upfield region of the ECA PG spectra, the peaks attributed to the N-acetyl groups and the C5-methyl (C5-CH 3 ) groups of Fuc4NAc can be straightforwardly assigned by such a comparison. These agree with previously published chemical shift assignments for ECA CYC to within 0.03 ppm 1 H and 0.3 ppm 13 C. Although the peak for the GlcNAc O-acetyl group of wild-type ECA PG should be well resolved from the other peaks in this spectrum, we observed a candidate for this peak that has chemical shifts that ppm). We suggest that this may be due to structural differences between ECA PG and ECA CYC since unlike ECA PG , the 6-O-acetylated GlcNAc of ECA CYC is placed in the center of a highly constrained cyclic structure (16) . To bolster our assignment, we treated the wild-type ECA PG with mild alkali to verify that this peak exhibited the alkaline sensitivity expected of an O-acetyl group. Indeed, our assignment was confirmed by the absence of detectable peaks in this region of the 13 C-1 H HSQC spectra of the alkaline treated glycolipid (Fig. 4B) . All of the spectra of ECA PG contain a significant number of unassigned peaks that are most likely due to either co-purifying compounds or to structural elements not found in ECA CYC ; e.g., fatty-acyl chains. In addition, the relative amounts of ECA PG and these co-purifying in the preparations obtained from the wild-type and yiaH::KAN-2 mutant appeared to be different. In this regard, it is important to note that the spectrum obtained from the yiaH::KAN-2 mutant (Fig. 4C ) was reproduced at a lower contour level than was the case for the spectra in panels A and B; nevertheless, no signal for an O-acetyl group was detected even though a very intense peak for the C5-CH 3 group was observed.
Based on our assignments, we used the peak intensities of the 
DISCUSSION
Earlier studies demonstrated that the hydroxyl group in the 6-position of GlcNAc residues in the polysaccharide moieties of both ECA PG and ECA CYC are nonstiochiometrically esterified with acetyl groups (14, 19, 28) . The data presented here clearly support the conclusion that the yiaH gene of E. coli K-12 encodes the enzyme responsible for the O-acetylation of these polysaccharides. This conclusion is supported by the results of both biochemical and genetic experiments that demonstrated that a null mutation in yiaH abolished the O-acetylation of both ECA PG and ECA CYC . Accordingly, we propose that this gene be henceforth designated as wecH.
It has been reported that WecH (YiaH) is an inner membrane protein (13) , and bioinformatic analysis of the putative primary structure of WecH predict that it possesses ten membrane-spanning segments (Fig. 3) . Details regarding the reaction catalyzed by A wide variety of bacterial pathogens possess cell surface polysaccharides that are O-acetylated (17, 18, 21, 25, 26, 32) , and this structural modification appears to be of considerable importance for host-pathogen interactions. In many cases the O-acetyl groups constitute prominent immunogenic epitopes that are important for the generation of host immune responses against the organism and for the development of protective vaccines (1, 8, 21, 26) . In contrast, the virulence of some bacterial pathogens appears to be enhanced by the O-acetylation of cell surface polysaccharides (1, 2, 9) . ECA PG is a component of all gram-negative enteric bacteria (23, 29, 31, 44) , and the available evidence strongly supports the conclusion that this is also the case for ECA CYC .
Moreover, the O-acetyl groups of ECA CYC , and presumably ECA PG as well, also appear to constitute prominent immunogenic epitopes. Accordingly, our data clearly demonstrate a marked decrease in the immunoreactivity of ECA CYC molecules devoid of O-acetyl groups with the polyclonal rabbit anti-ECA antiserum used in this study. (Fig. 4C ) was reproduced at a lower contour level than was the case for the spectra in panels A and B; nevertheless, no signal for an O-acetyl group was detected even though a very intense peak for the C5-CH 3 group was observed. 
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